Search for other papers by Xiaowen Zhang in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Drum Tower Clinical Medical College, Southeast University, Nanjing, China
Search for other papers by Chen Han in
Google Scholar
PubMed
Search for other papers by Hongwei Wang in
Google Scholar
PubMed
Search for other papers by Xinghong Sun in
Google Scholar
PubMed
Search for other papers by Xin Dou in
Google Scholar
PubMed
Search for other papers by Xueying He in
Google Scholar
PubMed
Search for other papers by Di Wu in
Google Scholar
PubMed
Search for other papers by Shanmei Shen in
Google Scholar
PubMed
Search for other papers by Dalong Zhu in
Google Scholar
PubMed
Search for other papers by Xinlin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Bi in
Google Scholar
PubMed
indicator of systemic inflammation. NLR has been reported to be associated with clinical prognosis in multiple disease contexts, including thyroid diseases ( 8 , 9 ). NLR predicts relapse in GD patients following antithyroid drug therapy ( 10 ) and disease
Search for other papers by Danzhou Fang in
Google Scholar
PubMed
Search for other papers by Shiying Li in
Google Scholar
PubMed
Search for other papers by Changgu Zhou in
Google Scholar
PubMed
Search for other papers by Yirui Wang in
Google Scholar
PubMed
Search for other papers by Gengbiao Yuan in
Google Scholar
PubMed
Search for other papers by HuiHui Zhang in
Google Scholar
PubMed
Search for other papers by Maohua Rao in
Google Scholar
PubMed
. Contemporary hyperthyroidism treatments encompass thyroidectomy, antithyroid drugs, and radioactive iodine ( 131 I) therapy ( 7 ). However, for those with hyperthyroidism and concomitant liver failure, surgery may not be feasible due to the requirement of near
Search for other papers by Yuegui Wang in
Google Scholar
PubMed
Search for other papers by Liwei Hong in
Google Scholar
PubMed
School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
Search for other papers by Caiyun Yang in
Google Scholar
PubMed
Quanzhou Medical College, Quanzhou, Fujian, China
Search for other papers by Guorong Lv in
Google Scholar
PubMed
Search for other papers by Kangjian Wang in
Google Scholar
PubMed
Search for other papers by Xuepeng Huang in
Google Scholar
PubMed
Search for other papers by Haolin Shen in
Google Scholar
PubMed
orbitopathy ( 5 ). Therapies for GD include antithyroid drugs (ATDs), thyroidectomy, or radioactive iodine (RAI) therapy. ATD has only a 50% success rate for most patients after 1 year of treatment, and it may cause side effects such as agranulocytosis
Search for other papers by Lian Duan in
Google Scholar
PubMed
Search for other papers by Han-Yu Zhang in
Google Scholar
PubMed
Search for other papers by Min Lv in
Google Scholar
PubMed
Search for other papers by Han Zhang in
Google Scholar
PubMed
Search for other papers by Yao Chen in
Google Scholar
PubMed
Search for other papers by Ting Wang in
Google Scholar
PubMed
Search for other papers by Yan Li in
Google Scholar
PubMed
Search for other papers by Yan Wu in
Google Scholar
PubMed
Search for other papers by Junfeng Li in
Google Scholar
PubMed
Search for other papers by Kefeng Li in
Google Scholar
PubMed
per 100,000 individuals per year ( 3 , 4 ). Current treatment for GD patients includes antithyroid drugs (ATDs), radioiodine therapy ( 131 I therapy) (RAI), and thyroidectomy ( 5 ). ATDs tend to have a higher failure rate. In addition, approximately
Search for other papers by Ruth Percik in
Google Scholar
PubMed
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Search for other papers by Safwaan Adam in
Google Scholar
PubMed
Search for other papers by Kate Young in
Google Scholar
PubMed
Royal Marsden Hospital, London, UK
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
reports of Graves’ disease resulting in persistent thyrotoxicosis requiring antithyroid drugs such as carbimazole ( 44 , 45 , 46 , 47 , 48 ). Graves’ disease should be considered if thyrotoxicosis persists for more than 4 weeks and in those who present
Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Shanshan Yu in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Chun Liu in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
lymphoma occurred at the time of the first diagnosis ( 16 ). The diagnosis of hyperthyroidism was defined as either having a decreased TSH value <0.56 µIU/mL or being treated with antithyroid drugs. The presence of hypothyroidism was defined as either
Search for other papers by Xingyao Tang in
Google Scholar
PubMed
Search for other papers by Zhi-Hui Song in
Google Scholar
PubMed
Search for other papers by Dawei Wang in
Google Scholar
PubMed
Search for other papers by Jinkui Yang in
Google Scholar
PubMed
Search for other papers by Marly Augusto Cardoso in
Google Scholar
PubMed
Search for other papers by Jian-Bo Zhou in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
Search for other papers by Rafael Simó in
Google Scholar
PubMed
study, the lack of data on treatment and the effects of treatment on thyroid dysfunction limited a more rigorous analysis. Some reports declared the impacts of antithyroid drugs on dementia ( 39 ). The influence of antithyroid drugs on dementia needs
Search for other papers by Qian Yang in
Google Scholar
PubMed
Search for other papers by Wencai Ke in
Google Scholar
PubMed
Search for other papers by Fanfan Pan in
Google Scholar
PubMed
Search for other papers by Xinmei Huang in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
step in thyroid hormone synthesis. Methimazole (MMI) is an established first-line therapy for GD in China and MMI-induced granulocytosis is dose-dependent ( 4 ). Antithyroid drug (ATD)-associated agranulocytosis is a rare but life-threatening event
Search for other papers by Waleed K W Al-Badri in
Google Scholar
PubMed
Search for other papers by Hinke Marijke Jellema in
Google Scholar
PubMed
Search for other papers by Arnaud R G G Potvin in
Google Scholar
PubMed
Search for other papers by Ruth M A van Nispen in
Google Scholar
PubMed
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Search for other papers by Peerooz Saeed in
Google Scholar
PubMed
. ( https://doi.org/10.4103/1119-3077.100620 ) 44 Fukao A Takamatsu J Kubota S Miyauchi A & Hanafusa T . The thyroid function of Graves’ disease patients is aggravated by depressive personality during antithyroid drug treatment
Search for other papers by Jia Liu in
Google Scholar
PubMed
Search for other papers by Min Liu in
Google Scholar
PubMed
Search for other papers by Zhe Chen in
Google Scholar
PubMed
Search for other papers by Yumei Jia in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
heterogeneous thyroid in a thyroid ultrasound ( 12 ). Individuals with systemic inflammatory disease, cancer, claustrophobia and metal implants were excluded. No subject had been administered levothyroxine or antithyroid drugs. Individuals who were pregnant